SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-275680
Filing Date
2021-09-17
Accepted
2021-09-17 08:32:03
Documents
12
Period of Report
2021-09-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d198573d8k.htm   iXBRL 8-K 22389
  Complete submission text file 0001193125-21-275680.txt   144162

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA prld-20210916.xsd EX-101.SCH 2883
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE prld-20210916_lab.xml EX-101.LAB 18123
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE prld-20210916_pre.xml EX-101.PRE 11399
5 EXTRACTED XBRL INSTANCE DOCUMENT d198573d8k_htm.xml XML 3395
Mailing Address 200 POWDER MILL ROAD WILMINGTON DE 19803
Business Address 200 POWDER MILL ROAD WILMINGTON DE 19803 (302) 547-3768
Prelude Therapeutics Inc (Filer) CIK: 0001678660 (see all company filings)

IRS No.: 811384762 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-39527 | Film No.: 211259295
SIC: 2834 Pharmaceutical Preparations